First Quarter 2023 Highlights
”In the first quarter, we made headway on our 2023 priorities. We invested significant capital to accrete ownership in Spring Health and Agreena and financed these investments by exiting our remaining shareholding in Teladoc – ending the quarter with a net cash position remaining above SEK 10bn. The market backdrop continued to be volatile, exacerbated by distress in the banking sector, impacting the financial ecosystem our growth companies form part of. The impact on Kinnevik and our investees was limited, but the events serve as an important reminder of the fragility of current markets and the importance of financial resilience in these uncertain times.”
Georgi Ganev, CEO of Kinnevik
Kinnevik in numbers
Per 31 March 2023
SEK55.5bn
Net asset value
+5%
Change in nav Q/Q
SEK198
Nav per share
(37%)
1 year tsr
+5%
5 year tsr
Conference Call 10am CEST
Welcome to listed to the conference call presenting the first quarter results 2023.
(listen only)
Those who wish to ask questions during the conference call are welcome to register via the below link. Participants will receive dial-in numbers and confirmation code upon registration. Please make sure to register and dial in a few minutes before the call begins.
(for participants)